HLB Group Stocks and Leader (Korea)
The HLB Group theme has 9 member stock(s) today, with an average return of +0.2%. The leading stock is HLB제넥스 (+3.8%, trading value 339,098,269).
The HLB Group theme consists of affiliates centered around HLB, engaged in pharmaceuticals, diagnostics, materials, and global businesses. Because new drug development and approval schedules frequently impact group-wide stock prices, individual stocks often move in tandem on a given day despite differences in business scope and sensitivity to issues.
Co-movement among affiliates is particularly pronounced during clinical trial or approval-related events, so it is helpful to monitor performance differences between the parent company and its subsidiaries. The leading stock on this page is determined by daily price change and does not guarantee clinical trial outcomes or approval prospects. Overlaps with the Bio/Pharma theme allow for comparison to separate group-specific catalysts from broader industry trends.
| Stock | Price | Return | Trading Value |
|---|---|---|---|
| HLB제넥스 | 2,340 | +3.8% | 339,098,269 |
| HLB생명과학 | 3,300 | +0.6% | 483,336,173 |
| HLB바이오스텝 | 5,280 | +0.6% | 3,324,529,645 |
| HLB | 39,900 | +0.5% | 12,514,123,775 |
| HLB글로벌 | 1,737 | +0.3% | 399,554,002 |
| HLB파나진 | 1,264 | -0.1% | 132,154,215 |
| HLB제약 | 9,490 | -0.2% | 1,597,839,710 |
| HLB이노베이션 | 14,020 | -1.0% | 1,025,206,105 |
| HLB테라퓨틱스 | 2,495 | -2.5% | 752,845,839 |
This page's data is for reference only and is not investment advice. Actual market data may differ.